Scientists test groundbreaking HIV vaccines in first human trial
NCT ID NCT06919016
Summary
This is the first human trial testing two new HIV vaccine candidates called DV700P-RNA and DV701B1.1-RNA. The study aims to check if these vaccines are safe and how well they trigger immune responses in healthy adults without HIV. Forty-five volunteers aged 18-55 will participate for about 16 months, receiving injections and having their blood tested regularly.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital (Site ID: 30007)
Boston, Massachusetts, 02215, United States
-
Columbia P&S CRS (Site ID: 30329)
New York, New York, 10032, United States
-
Seattle Vaccine and Prevention CRS (Site ID: 30331)
Seattle, Washington, 98104, United States
-
The Hope Clinic of the Emory Vaccine Center CRS (Site ID: 31440)
Decatur, Georgia, 30030, United States
-
University of Alabama Medical Center (Site ID: 31788)
Birmingham, Alabama, 35222, United States
-
University of Pittsburgh (Site ID: 1001)
Pittsburgh, Pennsylvania, 15213, United States
-
University of Rochester Medical Center (Site ID: 31467)
Rochester, New York, 14642, United States
-
Vanderbilt University Medical Center (Site ID: 30352)
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.